Megakaryocyte-Platelet Immunometabolism in Leukemic Niche Remodeling

Hoyeop Baek1, Kiwon Lee1

  • 1Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin 17035, Republic of Korea.

Cancers
|July 28, 2026
PubMed

Insights

The immune megakaryocyte (iMK)-platelet axis drives leukemia progression by remodeling the bone marrow niche. Targeting this axis, including mitochondrial stress and inflammation, offers new therapeutic strategies for leukemia.

Area of Science:

  • Hematology
  • Immunology
  • Cancer Biology

Background:

  • Megakaryocytes (MKs) and platelets are active regulators of the bone marrow microenvironment.
  • Megakaryopoiesis generates functionally diverse cell subsets influencing hematopoietic stem cells (HSCs) and vascular homeostasis.
  • Leukemia rewires these regulatory circuits, creating a niche that favors leukemic stem cells (LSCs).

Purpose of the Study:

  • To propose the immune MK (iMK)-platelet axis as a key driver of leukemic niche remodeling.
  • To explore how iMK states and MK heterogeneity contribute to niche instructions.
  • To highlight mitochondrial stress and platelet-derived extracellular vesicles (EVs) in inflammatory signaling.

Main Methods:

  • Review of recent single-cell and lineage-tracing studies.
  • Analysis of iMK states and MK heterogeneity under leukemic pressure.
  • Examination of platelet-derived EVs and mitochondrial stress outputs (mtROS, mtDNA, metabolic rewiring).

Main Results:

  • The iMK-platelet axis actively remodels the leukemic bone marrow niche.
  • MK heterogeneity dictates specific niche-regulatory instructions.
  • Platelet EVs and mitochondrial stress amplify inflammatory signals within the marrow and systemically.

Conclusions:

  • The iMK-platelet axis is central to leukemic niche remodeling.
  • Preleukemic inflammatory states present therapeutic intervention opportunities.
  • Targeting inflammatory niche, mitochondrial stress, and platelet-leukemia communication offers clinical potential.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...